New Century Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,029
Closed -$238K 2
2025
Q3
$238K Sell
1,029
-1,359
-57% -$277K 0.42% 55
2025
Q2
$443K Buy
2,388
+528
+28% +$98.1K 0.52% 52
2025
Q1
$390K Sell
1,860
-5,313
-74% -$1.03M 0.45% 75
2024
Q4
$1.3M Sell
7,173
-1,222
-15% -$225K 0.55% 42
2024
Q3
$1.66M Buy
8,395
+690
+9% +$129K 0.61% 34
2024
Q2
$1.32M Buy
7,705
+5,964
+343% +$988K 0.56% 35
2024
Q1
$317K Buy
1,741
+22
+1% +$3.79K 0.22% 123
2023
Q4
$266K Buy
+1,719
New +$251K 0.23% 129

Other funds holding ABBV

New Century Financial Group's ABBV Position: Q4 2025 in Review

New Century Financial Group sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 1,029 shares — an estimated $238K sold.

New Century Financial Group first reported a position in ABBV in Q4 2023 and held it in 8 quarters. The position peaked at $1.66M in Q3 2024. 4,147 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • New Century Financial Group reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • New Century Financial Group sold 1,029 AbbVie shares in Q4 2025, an estimated $238K.
  • New Century Financial Group first reported a position in AbbVie in Q4 2023 and held it in 8 quarters.
  • New Century Financial Group's AbbVie position peaked at $1.66M in Q3 2024.
  • 4,147 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on New Century Financial Group's 13F filing for Q4 2025.